XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
NCT00333359
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
581
Enrollment
INDUSTRY
Sponsor class
Conditions
Restless Legs Syndrome
Interventions
DRUG:
XP13512 (GEn)
Sponsor
XenoPort, Inc.